JP2012501631A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012501631A5 JP2012501631A5 JP2011525460A JP2011525460A JP2012501631A5 JP 2012501631 A5 JP2012501631 A5 JP 2012501631A5 JP 2011525460 A JP2011525460 A JP 2011525460A JP 2011525460 A JP2011525460 A JP 2011525460A JP 2012501631 A5 JP2012501631 A5 JP 2012501631A5
- Authority
- JP
- Japan
- Prior art keywords
- hna
- seq
- nucleic acid
- sample
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000523 sample Substances 0.000 claims 54
- 239000012634 fragment Substances 0.000 claims 52
- 150000007523 nucleic acids Chemical class 0.000 claims 51
- 108020004707 nucleic acids Proteins 0.000 claims 41
- 102000039446 nucleic acids Human genes 0.000 claims 41
- 108090000765 processed proteins & peptides Proteins 0.000 claims 37
- 229920001184 polypeptide Polymers 0.000 claims 34
- 102000004196 processed proteins & peptides Human genes 0.000 claims 34
- 239000012472 biological sample Substances 0.000 claims 21
- 230000000890 antigenic effect Effects 0.000 claims 15
- 125000003275 alpha amino acid group Chemical group 0.000 claims 14
- 238000000034 method Methods 0.000 claims 14
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 13
- 208000007587 Transfusion-Related Acute Lung Injury Diseases 0.000 claims 13
- 208000024908 graft versus host disease Diseases 0.000 claims 13
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims 12
- 239000002751 oligonucleotide probe Substances 0.000 claims 12
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 10
- 239000000427 antigen Substances 0.000 claims 10
- 108091007433 antigens Proteins 0.000 claims 10
- 102000036639 antigens Human genes 0.000 claims 10
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 9
- 108091034117 Oligonucleotide Proteins 0.000 claims 7
- 230000000735 allogeneic effect Effects 0.000 claims 7
- 239000013615 primer Substances 0.000 claims 7
- -1 HLA nucleic acid Chemical class 0.000 claims 6
- 238000009396 hybridization Methods 0.000 claims 6
- 238000002054 transplantation Methods 0.000 claims 5
- 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 claims 3
- 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims 3
- 102100022338 Integrin alpha-M Human genes 0.000 claims 3
- 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 3
- 210000004369 blood Anatomy 0.000 claims 3
- 108091033319 polynucleotide Proteins 0.000 claims 3
- 102000040430 polynucleotide Human genes 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 2
- 108091023037 Aptamer Proteins 0.000 claims 2
- 108020004705 Codon Proteins 0.000 claims 2
- 239000003155 DNA primer Substances 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 108090001008 Avidin Proteins 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 239000011324 bead Substances 0.000 claims 1
- 229960002685 biotin Drugs 0.000 claims 1
- 235000020958 biotin Nutrition 0.000 claims 1
- 239000011616 biotin Substances 0.000 claims 1
- 239000003914 blood derivative Substances 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 239000007850 fluorescent dye Substances 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 230000002285 radioactive effect Effects 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008045696.9 | 2008-09-04 | ||
| DE102008045696A DE102008045696A1 (de) | 2008-09-04 | 2008-09-04 | Granulozyten HNA-3a/b-Antigen |
| PCT/EP2009/006386 WO2010025915A1 (en) | 2008-09-04 | 2009-09-03 | Screening methods for transfusion related acute lung injury (trali) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012501631A JP2012501631A (ja) | 2012-01-26 |
| JP2012501631A5 true JP2012501631A5 (https=) | 2012-10-18 |
| JP5766606B2 JP5766606B2 (ja) | 2015-08-19 |
Family
ID=41266687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011525460A Active JP5766606B2 (ja) | 2008-09-04 | 2009-09-03 | 輸血関連急性肺障害（ｔｒａｌｉ）に関するスクリーニング方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US8084216B2 (https=) |
| EP (1) | EP2321644B1 (https=) |
| JP (1) | JP5766606B2 (https=) |
| CN (1) | CN102203609B (https=) |
| AU (2) | AU2009289809B2 (https=) |
| BR (1) | BRPI0918233B8 (https=) |
| CA (1) | CA2735138C (https=) |
| DE (1) | DE102008045696A1 (https=) |
| WO (1) | WO2010025915A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2162792A4 (en) | 2007-05-29 | 2011-08-24 | Lab Partners Associates Inc | SYSTEM AND METHOD FOR MAINTAINING FLASH CONTACT COMMUNICATIONS BETWEEN A CAMERA AND A WIRELESS DEVICE |
| WO2009114522A2 (en) * | 2008-03-10 | 2009-09-17 | Bonfils Blood Center | Compositions, kits and methods for determining etiology of trali and detecting patients at risk for this transfusion reaction |
| DE102008045696A1 (de) * | 2008-09-04 | 2010-03-11 | Drk Blutspendedienst West Ggmbh | Granulozyten HNA-3a/b-Antigen |
| WO2010059971A1 (en) * | 2008-11-21 | 2010-05-27 | Martin Heath Bluth | Diagnosing and monitoring response to treatment of non-incontinent urological and related diseases |
| WO2010065425A1 (en) | 2008-12-01 | 2010-06-10 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for detection of complement fixing antibodies |
| US10101337B2 (en) | 2013-03-14 | 2018-10-16 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of detecting donor-specific antibodies and systems for practicing the same |
| EP3140322B1 (en) * | 2014-05-09 | 2021-02-17 | One Lambda, Inc. | Modified fc gamma receptor type iii (fc iii, hna-1) polypeptides and the uses thereof |
| US10527613B2 (en) | 2015-11-10 | 2020-01-07 | The Board Of Trustees Of The Leland Stanford Junior University | Biomarker detection methods and systems and kits for practicing same |
| WO2017094733A1 (ja) * | 2015-11-30 | 2017-06-08 | 日産化学工業株式会社 | 分子標的医薬に結合するｄｎａアプタマー及びそれを用いる分子標的医薬の検出方法 |
| AU2016402264B2 (en) * | 2016-04-15 | 2024-08-22 | Pontificia Universidad Católica De Chile | Pharmaceutical composition for reducing the symptoms and disease of the respiratory infection caused by human metapneumovirus (HMPV), which comprises at least one agent that neutralises the function of the TSLP and/or TSLPR and/or OX40L and/or CD177 molecules, and a pharmaceutically acceptable excipient, and the use thereof |
| CN116083551B (zh) * | 2022-10-11 | 2025-02-21 | 南宁中心血站(南宁输血医学研究所) | 用于检测人类中性粒细胞抗原基因分型的引物组合、试剂盒及方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7368531B2 (en) | 1997-03-07 | 2008-05-06 | Human Genome Sciences, Inc. | Human secreted proteins |
| US7411051B2 (en) | 1997-03-07 | 2008-08-12 | Human Genome Sciences, Inc. | Antibodies to HDPPA04 polypeptide |
| US20030082646A1 (en) | 1998-12-29 | 2003-05-01 | The Regents Of The University Of Michigan | Antigenic targets of autoimmune sensorineural hearing loss (AISNHL) and development of tests for diagnosis and management of AISNHL |
| CA2383592A1 (en) | 1999-03-31 | 2000-10-05 | Curagen Corporation | 2384891 acids including open reading frames encoding polypeptides; orfx |
| US6943235B1 (en) | 1999-04-12 | 2005-09-13 | Agensys, Inc. | Transmembrane protein expressed in prostate cancer |
| EP1074617A3 (en) | 1999-07-29 | 2004-04-21 | Research Association for Biotechnology | Primers for synthesising full-length cDNA and their use |
| FR2800750B1 (fr) | 1999-11-05 | 2003-01-31 | Centre Nat Rech Scient | Proteines membranaires ctl (choline transporter like) impliquees dans le transport de la choline |
| DE10028725B4 (de) | 2000-06-09 | 2013-03-21 | Jürgen Bux | Primärstruktur des HNA-2a (ehemals NB1)-Antigens |
| US20040142325A1 (en) | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| US20030219777A1 (en) * | 2001-12-18 | 2003-11-27 | Lynx Therapeutics, Inc. | Identification of candidate genes for the atherosclerosis susceptibility locus (ATHS) |
| US7829292B2 (en) | 2002-05-06 | 2010-11-09 | The Regents Of The University Of Michigan | Compositions and methods for diagnosing, predicting therapeutic response of, and monitoring autoimmune disease |
| DE10228103A1 (de) | 2002-06-24 | 2004-01-15 | Bayer Cropscience Ag | Fungizide Wirkstoffkombinationen |
| CA2516128A1 (en) * | 2003-02-14 | 2004-09-02 | Sagres Discovery, Inc. | Therapeutic targets in cancer |
| US7303985B2 (en) | 2003-11-17 | 2007-12-04 | Intel Corporation | Zeolite-carbon doped oxide composite low k dielectric |
| WO2007108368A1 (ja) * | 2006-03-23 | 2007-09-27 | Japanese Red Cross Society | 顆粒球抗体の検出に用いられるパネル細胞 |
| DE102008045696A1 (de) * | 2008-09-04 | 2010-03-11 | Drk Blutspendedienst West Ggmbh | Granulozyten HNA-3a/b-Antigen |
-
2008
- 2008-09-04 DE DE102008045696A patent/DE102008045696A1/de not_active Withdrawn
-
2009
- 2009-09-03 CA CA2735138A patent/CA2735138C/en active Active
- 2009-09-03 AU AU2009289809A patent/AU2009289809B2/en active Active
- 2009-09-03 WO PCT/EP2009/006386 patent/WO2010025915A1/en not_active Ceased
- 2009-09-03 US US12/553,487 patent/US8084216B2/en active Active
- 2009-09-03 EP EP09778306.2A patent/EP2321644B1/en active Active
- 2009-09-03 CN CN200980144058.0A patent/CN102203609B/zh active Active
- 2009-09-03 JP JP2011525460A patent/JP5766606B2/ja active Active
- 2009-09-03 BR BRPI0918233A patent/BRPI0918233B8/pt active IP Right Grant
-
2011
- 2011-11-29 US US13/306,380 patent/US8435733B2/en active Active
-
2013
- 2013-03-18 US US13/845,898 patent/US8999651B2/en active Active
-
2015
- 2015-04-03 US US14/678,827 patent/US9963741B2/en active Active
-
2016
- 2016-06-17 AU AU2016204135A patent/AU2016204135A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012501631A5 (https=) | ||
| AU2023248207B2 (en) | Methods and compositions for identifying epitopes | |
| CN104789568B (zh) | 一种用于检测石斑鱼虹彩病毒感染的dna核酸适配体及其筛选方法和应用 | |
| CN111073892B (zh) | 一种识别石斑鱼虹彩病毒感染细胞的核酸适配体及其构建方法和应用 | |
| EP2108126A2 (en) | Pathogen binding | |
| BRPI0918233B1 (pt) | métodos de triagem para a lesão pulmonar aguda e doença do enxerto contra hospedeiro relacionada à transfusão ou transplante, kits e uso de polipeptídeos | |
| US20160370352A1 (en) | Assays and monitoring paradigms for stem cell culture | |
| RU2011140006A (ru) | Способ детекции вещества в биологическом образце | |
| KR102016668B1 (ko) | 치쿤군야 바이러스 e2에 특이적으로 결합하는 dna 압타머 및 이의 용도 | |
| US20120115146A1 (en) | Method of analyzing genetically abnormal cells | |
| CN105002300B (zh) | 一种鱼类神经坏死病毒现场快速高灵敏检测方法及试剂盒 | |
| CN112126649B (zh) | 基于工程化细胞的N-cadherin核酸适配体的筛选及应用 | |
| Esteve-Sanchez et al. | SARS-CoV-2 N protein IgG antibody detection employing nanoporous anodized alumina: A rapid and selective alternative for identifying naturally infected individuals in populations vaccinated with spike protein (S)-based vaccines | |
| EP2202244A1 (en) | Method of immunological analysis for detection of antibodies against human gstt1 (anti-hgstt1) | |
| CN104789570B (zh) | 一种用于检测石斑鱼虹彩病毒感染的dna核酸适配体及其筛选方法和应用 | |
| JP2022182394A (ja) | 抗原固相化デバイス | |
| WO2018082037A1 (zh) | 利用猪特异游离dna监测异种移植免疫排斥反应的方法和引物 | |
| CN119161463B (zh) | 一株乙型肝炎病毒核心蛋白的单克隆抗体cAbB4及其制备与应用 | |
| CN119101148B (zh) | 一株乙型肝炎病毒核心蛋白的单克隆抗体cAbF9及其制备与应用 | |
| CN119161465B (zh) | 一株乙型肝炎病毒核心蛋白的单克隆抗体cAbA1及其制备与应用 | |
| CN119161462B (zh) | 一株乙型肝炎病毒核心蛋白的单克隆抗体cAbD4及其制备与应用 | |
| JPWO2009147864A1 (ja) | １細胞レベルでの抗体遺伝子の解析・同定方法 | |
| KR20120052801A (ko) | Ｒｔ－ｐｃｒ ｅｌｉｓａ를 이용한 ｅ형 간염 바이러스 검출방법 및 키트 | |
| Lee et al. | DETERMINATION OF MILTENBERGER BLOOD GROUP ANTIGENS BY DIRECT BLOOD PCR: 3D-S9–04 | |
| CN119161464A (zh) | 针对乙型肝炎病毒核心蛋白的单克隆抗体及其制备与应用 |